Ipamorelin
NNC-26-0161
A highly selective GH secretagogue and ghrelin receptor agonist known for clean GH release without significant cortisol or prolactin stimulation.
Half-Life
~2 hours
MW
711.86 Da
Amino Acids
5 AA
Evidence
Moderate Evidence
Regulatory Status
Research compound. FDA-approved trials for GI motility disorders (different indication).
Research reference values only. Confirm all parameters with current literature and your clinician.
Looking for multi-compound protocols?
Browse educational protocol discussions that include Ipamorelin.
Related Compounds
CJC-1295
A long-acting GHRH analogue with a Drug Affinity Complex that extends its half-life dramatically, allowing weekly dosing for sustained GH elevation.
Sermorelin
A 29-amino acid truncated analogue of endogenous GHRH, FDA-approved for pediatric GHD and widely researched for anti-aging and body composition.
GHRP-2
A potent GH secretagogue with strong ghrelin receptor activity, producing significant GH pulses with some cortisol and prolactin elevation.
Hexarelin
The most potent GH secretagogue peptide available, with additional direct cardiac and anti-fibrotic research applications.
Educational Disclaimer: All information on this page is for educational and research purposes only. This does not constitute medical advice, diagnosis, or treatment recommendation. Consult a qualified healthcare professional.